| Tucker Psychiatric Clinic Inc. | |
|
7149 Jahnke Rd Richmond VA 23225-4017 | |
| (804) 320-7881 | |
| (804) 320-2050 |
| Full Name | Tucker Psychiatric Clinic Inc. |
|---|---|
| Speciality | Counselor |
| Location | 7149 Jahnke Rd, Richmond, Virginia |
| Authorized Official Name and Position | David Gould (PRESIDENT) |
| Authorized Official Contact | 8043207881 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tucker Psychiatric Clinic Inc. 7149 Jahnke Rd Richmond VA 23225-4017 Ph: (804) 320-7881 | Tucker Psychiatric Clinic Inc. 7149 Jahnke Rd Richmond VA 23225-4017 Ph: (804) 320-7881 |
| NPI Number | 1003911256 |
|---|---|
| Provider Enumeration Date | 09/13/2006 |
| Last Update Date | 02/28/2008 |
| Medicare PECOS PAC ID | 9133018922 |
|---|---|
| Medicare Enrollment ID | O20040311000266 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003911256 | NPI | - | NPPES |
| Provider Name | Catherine B Thorne |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1396735619 PECOS PAC ID: 2567445687 Enrollment ID: I20040610000378 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Jesse Rabinowitz |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1952469009 PECOS PAC ID: 6608963806 Enrollment ID: I20071105000506 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Kate J Ray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073794285 PECOS PAC ID: 6901981414 Enrollment ID: I20080307000498 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Charles E Hall |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1598973471 PECOS PAC ID: 2062582786 Enrollment ID: I20080605000817 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | David W Gould |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629068077 PECOS PAC ID: 9335246982 Enrollment ID: I20100825001134 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Walter Stanley Jennings |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629068242 PECOS PAC ID: 2961509518 Enrollment ID: I20100830001036 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Richard Earl Curtis |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1972593598 PECOS PAC ID: 2062519614 Enrollment ID: I20100901000054 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | William D Kernodle |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1699765024 PECOS PAC ID: 9234236886 Enrollment ID: I20100901000074 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Robert L Seward |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1063402600 PECOS PAC ID: 0042317695 Enrollment ID: I20100901000120 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Elliott J Spanier |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1770573396 PECOS PAC ID: 0143327791 Enrollment ID: I20100901000140 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Sharlene Patricia Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1588747869 PECOS PAC ID: 6204095433 Enrollment ID: I20120308000002 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Jason Kudurogianis |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205192077 PECOS PAC ID: 2567740269 Enrollment ID: I20171009001791 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Robin L Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1144808833 PECOS PAC ID: 9032512868 Enrollment ID: I20210730001086 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | James C Kwiatkowski |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225607906 PECOS PAC ID: 6608266812 Enrollment ID: I20211202001067 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
| Provider Name | Latasha Coett Matthews |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245018381 PECOS PAC ID: 8921458241 Enrollment ID: I20231229000241 |
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
News Archive
A UK survey of more than 2,000 young women has shown that many delay or avoid having a smear test due to feeling scared, vulnerable, or embarrassed.
A defective gene linked to autism influences how neurons connect and communicate with each other in the brain, according to a study from Washington University School of Medicine in St. Louis. Rodents that lack the gene form too many connections between brain neurons and have difficulty learning.
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.
As he grew older, Dale Kunitomi paid closer attention to his health — and to his doctor's advice. When he noticed rectal bleeding in 2010, he went to see his physician, who ordered a colonoscopy.
› Verified 3 days ago
Broad Rock Counseling And Training Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2545 Bellwood Road, Suite 112, Richmond, VA 23237 Phone: 804-275-9980 Fax: 804-275-9981 | |
Pbs Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3018 W Clay St, Suite 204, Richmond, VA 23230 Phone: 804-447-4629 Fax: 804-447-4629 | |
Capstone Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1803 N 28th St, Richmond, VA 23223 Phone: 804-525-5386 Fax: 804-442-7069 | |
Rowe Counseling Services, Llc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 116 Brandon Rd Suite 117, Richmond, VA 23224 Phone: 804-677-1733 Fax: 804-230-1723 | |
Watchtower Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 800 Semmes Ave Apt 613, Richmond, VA 23224 Phone: 804-929-8229 | |
You Matter Residential Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 S 5th St, Richmond, VA 23219 Phone: 804-447-6590 Fax: 804-447-3516 | |
New Living Serivices Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1806 Summit Ave Ste 300, Richmond, VA 23230 Phone: 804-358-9679 |